StockWatch
·
Healthcare Service Provider
Board Meeting17 Jul 2026, 01:15 pm

Dr. Lal PathLabs Board to Consider Interim Dividend

AI Summary

Dr. Lal PathLabs Ltd has announced a board meeting scheduled for July 24, 2026. The primary agenda is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the board will evaluate the possibility of declaring an interim dividend for the financial year 2026-27. This follows a previous intimation on June 29, 2026, regarding the board meeting schedule.

Key Highlights

  • Board meeting on July 24, 2026, to approve Q1 FY27 financial results.
  • Unaudited standalone and consolidated results will be presented.
  • Interim dividend for FY27 will be considered by the board.
  • This is a continuation of earlier intimation dated June 29, 2026.